Our rapid response platform allows physicians to upload cases and receive fast quantification results, regardless of where they sit - the emergency department, radiology, pulmonology, or at home. The Eureka Clinical AI Emergency Lung AI Suite delivers newly enhanced segmentation and automated measurementcapabilities within a guided workflow for the disease progression assessment and quantification of COVID-19 and other lung related illness.*
Improving Patient Outcomes through AI-driven Insights
Achieve faster and better-informed careleveraging purpose built and easy-to-consume interpretation solutions.
Strengthen clinical decision makingand diagnosis with AI-driven imaging insights in immersive and intuitive dashboards.
Increase confidenceby using technology noted as the ground truth for accuracy and precision in advanced image processing.
Fast Access to Lung Quantification Results & Tissue Characterization
Physicians can more quickly & effectively identify disease impact, determine progression or improvement, and suggest additional or follow-up treatment required for better patient outcomes.
Reduce physician stress and fatigue by eliminating repetitive, manual tasks.
No installation required – immediate access.
LungAI Workflow Key Features
The LungAI workflow leverages TeraRecon's data science expertise to rapidly deliver an automated lung experience that delivers zero-click segmentation and histogram results based on physician-customized thresholds. The results of these studies are available for review and adjustment prior to image archival - maintaining physician control.
AI Results Explorer: Review, Adjust & Re-Run Capabilities
Email notification of available results (HIPAA compliant)
Take a Step-by-Step Tour
Our rapid response platform allows physicians to upload cases and receive fast quantification results, regardless of where they sit - the emergency department, radiology, pulmonology, or at home.
*The following are important statements regarding the use of this tool:
Volumetric histogram and lung segmentation functionality are FDA cleared features of Intuition. This functionality is not FDA cleared specifically for COVID-19. It must only be used as an aid and that final interpretation should be performed by a licensed healthcare practitioner with the appropriate training.
The results should not be used for screening and the software does not provide specific disease detection and should not be solely or primarily relied upon to diagnose or treat COVID-19.
This device is not indicated for the diagnosis of COVID-19 and that in vitro diagnostic testing is currently the only definitive method to diagnose COVID-19.
This tool is available by specific licenses only.
The default thresholds are generalized recommendations and limits for device performance when used in an U.S. population. The image analysis should only be used as an aid and the final interpretation should be performed by a licensed healthcare practitioner with the appropriate training.